Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BIOMARIN PHARMACEUTICAL INC.”

112 pharma patents match "BIOMARIN PHARMACEUTICAL INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 112
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 112 pharmaceutical patents matching "BIOMARIN PHARMACEUTICAL INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

112 results for “BIOMARIN PHARMACEUTICAL INC.” · 30,257 patents in full index Clear search

  1. US 9834588

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted
  2. US 9814762

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  3. US 9796999

    Detection of oligosaccharides

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  4. US 9796664

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted
  5. US 9771408

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  6. US 9572870

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 21, 2017 · Expires Feb 16, 2037

    granted
  7. US 9567572

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  8. US 9540395

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

    granted
  9. US 9512143

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  10. US 9504762

    Adeno-associated virus factor VIII vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  11. US 9469683

    Lysosomal targeting peptides and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted
  12. US 9433624

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted
  13. US 9376480

    Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 28, 2016 · Expires Jun 23, 2036

    granted
  14. US 9265734

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  15. US 9216178

    Dry blend formulation of tetrahydrobiopterin

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  16. US 9200264

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  17. US 9089566

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted
  18. US 9044473

    Delivery of therapeutic compounds to the brain and other tissues

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  19. US 9029530

    Detection of oligosaccharides

    BIOMARIN PHARMACEUTICAL INC. · Granted May 12, 2015 · Expires May 7, 2035

    granted
  20. US 9018201

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiency

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 28, 2015 · Expires Apr 23, 2035

    granted
  21. US 8999987

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted
  22. US 8957066

    Histone deacetylase inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted
  23. US 8940513

    Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Jan 27, 2015 · Expires Jan 22, 2035

    granted
  24. US 8859498

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted